Page 5 - U11248 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from U11248. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In U11248 Today - Breaking & Trending Today

ADC With Radiotherapy for Brain Mets Ups Risk of Necrosis

An antibody-drug conjugate given concurrently with stereotactic radiotherapy to treat brain metastases may increase patients risk for symptomatic radiation necrosis, a study suggests. ....

New York , United States , Memorial Sloan Kettering Cancer Center , Emilys Lebow , Malignant Head And Neck Neoplasm , Brain Metastasis , Metastatic Brain Tumor , Tereotactic Radiotherapy , Radiation Oncology , Radiation Necrosis , Biologic Therapy , Hodgkins Lymphoma , Antibody Drug Conjugates Adcs , Antineoplastic Drug , Nti Cancer Agents , Humanized Monoclonal Antibody ,

Trial Shows Precision Medicine in RA 'Remains Elusive'

Histologic analysis did not sufficiently predict treatment response to certain medications, but methods involving gene expression and transcriptome analysis may be more promising. ....

United States , University Medical Center , United Kingdom , Mayo Clinic In Rochester , Elena Myasoedova , Harrisr Perlman , Costantino Pitzalis , Queen Mary University Of London , Leiden University Medical Center , American College Of Rheumatology , Inflammatory Arthritis Subspecialty Group , European Union , Northwestern University Feinberg School Of Medicine , Centre For Experimental Medicine , Experimental Medicine , Queen Mary University , Helm Van Mil , Biological Therapies , Biologic Naive Patients With Rheumatoid Arthritis , American College , Northwestern University Feinberg School , Mayo Clinic , Rheumatoid Arthritis , Biologic Therapy , Antineoplastic Drug , Nti Cancer Agents ,

Investigational ADC Improves PFS in Metastatic Breast Cancer

Datopotamab deruxtecan led to better progression-free survival and safety compared with standard chemotherapy in patients with metastatic HER-2 negative breast cancer. ....

United States , New York , Memorial Sloan Kettering Cancer Center , Sarat Chandarlapaty , Aditya Bardia , Cancer Center , European Society For Medical Oncology Congress , Mass General Cancer Center , Medical Oncology , Metastatic Breast Carcinoma , Breast Cancer , Alignant Breast Neoplasm , Her2 Negative Breast Cancer , Her2 Breast Cancer , Biologic Therapy , Alignant Neoplasia , Antineoplastic Drug , Nti Cancer Agents , Antibody Drug Conjugates Adcs , Endocrine Therapy , Hodgkins Lympho ,

UCSF's Dr Stephen Hauser Sketches MS Future

A neurology professor talks about the need to identify early biomarkers of MS, describes a three-stage model for the disease, and ponders how to define cure in this setting. ....

San Francisco , United States , Stephen Hauser , Drug Administration , Us Department Of Defense , University Of California , Multiple Sclerosis Ms , Multiple Sclerosis , Iological Marker , Genomic Medicine , Edicine Genomic , Tyrosine Kinase Inhibitor , Biologic Therapy , Autoimmune Disease ,

Takeda Announces Voluntary Withdrawal of Lung Cancer Therapy

The company said on Monday it will voluntarily withdraw its lung cancer therapy from the US after it failed to meet the main goal in a late-stage study. ....

United States , South Korea , Takeda Exkivity , Sriparna Roy , Shilpi Majumdar , Shinjini Ganguli , European Union , Drug Administration , Takeda Pharmaceutical , Lung Cancer , Ung Carcinoma , Ancer Of The Lung , Non Small Cell Lung Cancer , Alignant Neoplasia , Alignant Neoplasm , Tyrosine Kinase Inhibitor , Experimental Drug ,